| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADMET modeling approaches in drug discovery
|
Ferreira, Leonardo L.G.
|
|
|
24 |
5 |
p. 1157-1165
|
artikel
|
| 2 |
Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery
|
Colclough, Nicola
|
|
|
24 |
5 |
p. 1067-1073
|
artikel
|
| 3 |
Capturing and applying knowledge to guide compound optimisation
|
Segall, Matthew
|
|
|
24 |
5 |
p. 1074-1080
|
artikel
|
| 4 |
Contents page 2
|
|
|
|
24 |
5 |
p. ii
|
artikel
|
| 5 |
Contents page 1
|
|
|
|
24 |
5 |
p. i
|
artikel
|
| 6 |
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design
|
O’Reilly, Marc
|
|
|
24 |
5 |
p. 1081-1086
|
artikel
|
| 7 |
Expanding the activity spectrum of antiviral agents
|
Ianevski, Aleksandr
|
|
|
24 |
5 |
p. 1224-1228
|
artikel
|
| 8 |
Exploration of biomedical dendrimer space based on in-vitro physicochemical parameters: key factor analysis (Part 1)
|
Mignani, Serge
|
|
|
24 |
5 |
p. 1176-1183
|
artikel
|
| 9 |
Exploration of biomedical dendrimer space based on in-vivo physicochemical parameters: Key factor analysis (Part 2)
|
Mignani, Serge
|
|
|
24 |
5 |
p. 1184-1192
|
artikel
|
| 10 |
Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art
|
Vahdat Lasemi, Fatemeh
|
|
|
24 |
5 |
p. 1116-1131
|
artikel
|
| 11 |
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
|
Karami, Zahra
|
|
|
24 |
5 |
p. 1104-1115
|
artikel
|
| 12 |
Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome
|
Chaturvedi, Swati
|
|
|
24 |
5 |
p. 1166-1175
|
artikel
|
| 13 |
New targets for HIV drug discovery
|
Puhl, Ana C.
|
|
|
24 |
5 |
p. 1139-1147
|
artikel
|
| 14 |
Organ-on-a-chip technology: turning its potential for clinical benefit into reality
|
Haddrick, Malcolm
|
|
|
24 |
5 |
p. 1217-1223
|
artikel
|
| 15 |
The next level in chemical space navigation: going far beyond enumerable compound libraries
|
Hoffmann, Torsten
|
|
|
24 |
5 |
p. 1148-1156
|
artikel
|
| 16 |
Therapeutic implications of novel peptides targeting ER–mitochondria Ca2+-flux systems
|
Kerkhofs, Martijn
|
|
|
24 |
5 |
p. 1092-1103
|
artikel
|
| 17 |
Therapy for glioblastoma: is it working?
|
Zanders, Edward D.
|
|
|
24 |
5 |
p. 1193-1201
|
artikel
|
| 18 |
The role of mitochondrial DNA in breast tumors
|
Weerts, Marjolein J.A.
|
|
|
24 |
5 |
p. 1202-1208
|
artikel
|
| 19 |
The search for biosimilars and biobetters
|
Burchiel, Scott W.
|
|
|
24 |
5 |
p. 1087-1091
|
artikel
|
| 20 |
Walking a tightrope: drug discovery in visceral leishmaniasis
|
Balaña-Fouce, Rafael
|
|
|
24 |
5 |
p. 1209-1216
|
artikel
|
| 21 |
Where are we with monoclonal antibodies for multidrug-resistant infections?
|
McConnell, Michael J.
|
|
|
24 |
5 |
p. 1132-1138
|
artikel
|
Tijdschrift beschrijving